nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolbutamide—type 2 diabetes mellitus—polycystic ovary syndrome	0.939	1	CtDrD
Tolbutamide—CYP2C19—urine—polycystic ovary syndrome	0.00208	0.102	CbGeAlD
Tolbutamide—CYP2C9—urine—polycystic ovary syndrome	0.00161	0.0788	CbGeAlD
Tolbutamide—Reaction gastrointestinal—Metformin—polycystic ovary syndrome	0.00134	0.355	CcSEcCtD
Tolbutamide—Gliclazide—VEGFA—polycystic ovary syndrome	0.00103	0.565	CrCbGaD
Tolbutamide—CYP2C18—vagina—polycystic ovary syndrome	0.000867	0.0424	CbGeAlD
Tolbutamide—ABCC8—endometrium—polycystic ovary syndrome	0.000853	0.0417	CbGeAlD
Tolbutamide—SLC15A1—endometrium—polycystic ovary syndrome	0.000816	0.0398	CbGeAlD
Tolbutamide—CYP2C18—endocrine gland—polycystic ovary syndrome	0.000811	0.0396	CbGeAlD
Tolbutamide—Glipizide—PPARG—polycystic ovary syndrome	0.000789	0.435	CrCbGaD
Tolbutamide—ABCC8—pituitary gland—polycystic ovary syndrome	0.000772	0.0377	CbGeAlD
Tolbutamide—KCNJ11—adrenal gland—polycystic ovary syndrome	0.000749	0.0366	CbGeAlD
Tolbutamide—KCNJ11—female gonad—polycystic ovary syndrome	0.000698	0.0341	CbGeAlD
Tolbutamide—ABCC8—adrenal gland—polycystic ovary syndrome	0.00069	0.0337	CbGeAlD
Tolbutamide—KCNJ11—endocrine gland—polycystic ovary syndrome	0.000649	0.0317	CbGeAlD
Tolbutamide—Heartburn—Metformin—polycystic ovary syndrome	0.000648	0.172	CcSEcCtD
Tolbutamide—SLCO2B1—uterus—polycystic ovary syndrome	0.000615	0.0301	CbGeAlD
Tolbutamide—SLC15A1—vagina—polycystic ovary syndrome	0.000611	0.0299	CbGeAlD
Tolbutamide—SLCO2B1—adipose tissue—polycystic ovary syndrome	0.000602	0.0294	CbGeAlD
Tolbutamide—ABCC8—endocrine gland—polycystic ovary syndrome	0.000598	0.0292	CbGeAlD
Tolbutamide—SLC15A1—endocrine gland—polycystic ovary syndrome	0.000572	0.0279	CbGeAlD
Tolbutamide—SLCO2B1—adrenal gland—polycystic ovary syndrome	0.00054	0.0264	CbGeAlD
Tolbutamide—SLC15A2—endometrium—polycystic ovary syndrome	0.00051	0.0249	CbGeAlD
Tolbutamide—SLCO2B1—female gonad—polycystic ovary syndrome	0.000503	0.0246	CbGeAlD
Tolbutamide—SLCO2B1—endocrine gland—polycystic ovary syndrome	0.000468	0.0229	CbGeAlD
Tolbutamide—SLC15A2—pituitary gland—polycystic ovary syndrome	0.000461	0.0225	CbGeAlD
Tolbutamide—SLCO1A2—endocrine gland—polycystic ovary syndrome	0.000431	0.021	CbGeAlD
Tolbutamide—CYP2C8—endometrium—polycystic ovary syndrome	0.000429	0.021	CbGeAlD
Tolbutamide—SLC15A2—adrenal gland—polycystic ovary syndrome	0.000412	0.0201	CbGeAlD
Tolbutamide—CYP2C8—pituitary gland—polycystic ovary syndrome	0.000389	0.019	CbGeAlD
Tolbutamide—SLC15A2—female gonad—polycystic ovary syndrome	0.000384	0.0188	CbGeAlD
Tolbutamide—SLC15A2—vagina—polycystic ovary syndrome	0.000382	0.0187	CbGeAlD
Tolbutamide—CYP2C19—vagina—polycystic ovary syndrome	0.000369	0.018	CbGeAlD
Tolbutamide—SLC15A2—endocrine gland—polycystic ovary syndrome	0.000357	0.0175	CbGeAlD
Tolbutamide—CYP2C19—endocrine gland—polycystic ovary syndrome	0.000345	0.0168	CbGeAlD
Tolbutamide—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.000332	0.0883	CcSEcCtD
Tolbutamide—CYP2C8—vagina—polycystic ovary syndrome	0.000322	0.0157	CbGeAlD
Tolbutamide—CYP2C8—endocrine gland—polycystic ovary syndrome	0.000301	0.0147	CbGeAlD
Tolbutamide—Abdominal distension—Metformin—polycystic ovary syndrome	0.000282	0.0749	CcSEcCtD
Tolbutamide—CYP2C9—endocrine gland—polycystic ovary syndrome	0.000267	0.0131	CbGeAlD
Tolbutamide—Erythema—Metformin—polycystic ovary syndrome	0.000195	0.0519	CcSEcCtD
Tolbutamide—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000156	0.0414	CcSEcCtD
Tolbutamide—Dyspepsia—Metformin—polycystic ovary syndrome	0.00014	0.0373	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000137	0.0365	CcSEcCtD
Tolbutamide—Urticaria—Metformin—polycystic ovary syndrome	0.000126	0.0336	CcSEcCtD
Tolbutamide—Pruritus—Metformin—polycystic ovary syndrome	0.000113	0.0299	CcSEcCtD
Tolbutamide—Rash—Metformin—polycystic ovary syndrome	0.0001	0.0267	CcSEcCtD
Tolbutamide—Headache—Metformin—polycystic ovary syndrome	9.96e-05	0.0265	CcSEcCtD
Tolbutamide—Nausea—Metformin—polycystic ovary syndrome	9.45e-05	0.0251	CcSEcCtD
Tolbutamide—CYP2C19—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	2.86e-05	0.000822	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—AKR1C1—polycystic ovary syndrome	2.85e-05	0.000821	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PNPLA2—polycystic ovary syndrome	2.84e-05	0.000816	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	2.83e-05	0.000816	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	2.83e-05	0.000815	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	2.8e-05	0.000807	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	2.79e-05	0.000804	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—AKR1C1—polycystic ovary syndrome	2.77e-05	0.000796	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	2.72e-05	0.000784	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—HMMR—polycystic ovary syndrome	2.7e-05	0.000777	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—SRD5A1—polycystic ovary syndrome	2.69e-05	0.000774	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	2.65e-05	0.000762	CbGpPWpGaD
Tolbutamide—CYP2C9—Biological oxidations—CYP19A1—polycystic ovary syndrome	2.64e-05	0.00076	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	2.63e-05	0.000758	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—SULT2A1—polycystic ovary syndrome	2.63e-05	0.000756	CbGpPWpGaD
Tolbutamide—CYP2C8—Biological oxidations—CYP1A1—polycystic ovary syndrome	2.61e-05	0.000753	CbGpPWpGaD
Tolbutamide—CYP2C9—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	2.6e-05	0.00075	CbGpPWpGaD
Tolbutamide—CYP2C8—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	2.58e-05	0.000742	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—HSD3B1—polycystic ovary syndrome	2.57e-05	0.000741	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—STAR—polycystic ovary syndrome	2.56e-05	0.000738	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	2.56e-05	0.000738	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	2.55e-05	0.000733	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—SULT2A1—polycystic ovary syndrome	2.55e-05	0.000733	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—RRM2—polycystic ovary syndrome	2.54e-05	0.000732	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.54e-05	0.00073	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	2.53e-05	0.000727	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—RRM2—polycystic ovary syndrome	2.47e-05	0.00071	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—YAP1—polycystic ovary syndrome	2.45e-05	0.000705	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	2.41e-05	0.000695	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	2.41e-05	0.000694	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	2.41e-05	0.000693	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—YAP1—polycystic ovary syndrome	2.38e-05	0.000684	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—NAMPT—polycystic ovary syndrome	2.35e-05	0.000678	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—LHB—polycystic ovary syndrome	2.35e-05	0.000676	CbGpPWpGaD
Tolbutamide—CYP2C19—Biological oxidations—CYP1A1—polycystic ovary syndrome	2.33e-05	0.000672	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—CYP11A1—polycystic ovary syndrome	2.33e-05	0.000669	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	2.3e-05	0.000663	CbGpPWpGaD
Tolbutamide—CYP2C19—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	2.3e-05	0.000663	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—NMNAT3—polycystic ovary syndrome	2.3e-05	0.000662	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—HSD3B2—polycystic ovary syndrome	2.29e-05	0.000661	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—HMMR—polycystic ovary syndrome	2.29e-05	0.000658	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—NAMPT—polycystic ovary syndrome	2.28e-05	0.000657	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—CYP11A1—polycystic ovary syndrome	2.25e-05	0.000649	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—AKR1C1—polycystic ovary syndrome	2.22e-05	0.00064	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—AKR1C3—polycystic ovary syndrome	2.2e-05	0.000632	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	2.19e-05	0.000632	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—HSD3B1—polycystic ovary syndrome	2.18e-05	0.000628	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—CYP17A1—polycystic ovary syndrome	2.16e-05	0.000622	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.16e-05	0.00062	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	2.15e-05	0.000619	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	2.15e-05	0.000618	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	2.14e-05	0.000617	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—AKR1C3—polycystic ovary syndrome	2.13e-05	0.000613	CbGpPWpGaD
Tolbutamide—CYP2C9—Biological oxidations—CYP1A1—polycystic ovary syndrome	2.13e-05	0.000613	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—LPCAT2—polycystic ovary syndrome	2.1e-05	0.000606	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—SUOX—polycystic ovary syndrome	2.1e-05	0.000606	CbGpPWpGaD
Tolbutamide—CYP2C9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	2.1e-05	0.000604	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—CYP17A1—polycystic ovary syndrome	2.1e-05	0.000603	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	2.08e-05	0.000598	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—NMNAT3—polycystic ovary syndrome	2.05e-05	0.000591	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—SULT2A1—polycystic ovary syndrome	2.05e-05	0.000589	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.04e-05	0.000588	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	2.02e-05	0.000582	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—LHB—polycystic ovary syndrome	1.99e-05	0.000572	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—RRM2—polycystic ovary syndrome	1.98e-05	0.00057	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	1.96e-05	0.000564	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	1.96e-05	0.000564	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ISYNA1—polycystic ovary syndrome	1.96e-05	0.000563	CbGpPWpGaD
Tolbutamide—CYP2C8—Biological oxidations—POMC—polycystic ovary syndrome	1.95e-05	0.000561	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—HSD3B2—polycystic ovary syndrome	1.94e-05	0.000559	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	1.91e-05	0.000551	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	1.91e-05	0.00055	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—YAP1—polycystic ovary syndrome	1.91e-05	0.00055	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—AKR1C1—polycystic ovary syndrome	1.88e-05	0.000542	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—LPCAT2—polycystic ovary syndrome	1.88e-05	0.000541	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—SUOX—polycystic ovary syndrome	1.88e-05	0.000541	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—NMNAT3—polycystic ovary syndrome	1.87e-05	0.000539	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—TH—polycystic ovary syndrome	1.87e-05	0.000538	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	1.85e-05	0.000534	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—NAMPT—polycystic ovary syndrome	1.83e-05	0.000528	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—SLC2A4—polycystic ovary syndrome	1.82e-05	0.000524	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—TH—polycystic ovary syndrome	1.81e-05	0.000522	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—CYP11A1—polycystic ovary syndrome	1.81e-05	0.000521	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	1.79e-05	0.000514	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	1.78e-05	0.000514	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—SLC2A4—polycystic ovary syndrome	1.76e-05	0.000508	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ISYNA1—polycystic ovary syndrome	1.75e-05	0.000502	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	1.75e-05	0.000502	CbGpPWpGaD
Tolbutamide—CYP2C19—Biological oxidations—POMC—polycystic ovary syndrome	1.74e-05	0.000501	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—SULT2A1—polycystic ovary syndrome	1.73e-05	0.000499	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	1.71e-05	0.000493	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	1.71e-05	0.000493	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—CYP19A1—polycystic ovary syndrome	1.71e-05	0.000492	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—AKR1C3—polycystic ovary syndrome	1.71e-05	0.000492	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	1.71e-05	0.000491	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	1.69e-05	0.000487	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	1.69e-05	0.000487	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—CYP17A1—polycystic ovary syndrome	1.68e-05	0.000485	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—RRM2—polycystic ovary syndrome	1.68e-05	0.000483	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—AKR1C2—polycystic ovary syndrome	1.66e-05	0.000479	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—TEAD2—polycystic ovary syndrome	1.66e-05	0.000479	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—CYP19A1—polycystic ovary syndrome	1.66e-05	0.000478	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—YAP1—polycystic ovary syndrome	1.62e-05	0.000466	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	1.6e-05	0.00046	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	1.59e-05	0.000458	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	1.59e-05	0.000458	CbGpPWpGaD
Tolbutamide—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	1.59e-05	0.000457	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	1.57e-05	0.000453	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	1.56e-05	0.000448	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—NAMPT—polycystic ovary syndrome	1.55e-05	0.000447	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.54e-05	0.000445	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CYP11A1—polycystic ovary syndrome	1.53e-05	0.000442	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—GNAS—polycystic ovary syndrome	1.53e-05	0.00044	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.52e-05	0.000439	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	1.51e-05	0.000435	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—TEAD2—polycystic ovary syndrome	1.48e-05	0.000427	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—AKR1C2—polycystic ovary syndrome	1.48e-05	0.000427	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—GNAS—polycystic ovary syndrome	1.48e-05	0.000426	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—TH—polycystic ovary syndrome	1.46e-05	0.000419	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—NCOR1—polycystic ovary syndrome	1.45e-05	0.000419	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	1.45e-05	0.000418	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—AKR1C3—polycystic ovary syndrome	1.45e-05	0.000417	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	1.43e-05	0.000411	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CYP17A1—polycystic ovary syndrome	1.43e-05	0.000411	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—SLC2A4—polycystic ovary syndrome	1.42e-05	0.000408	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—NCOR1—polycystic ovary syndrome	1.41e-05	0.000406	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	1.4e-05	0.000404	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PNPLA2—polycystic ovary syndrome	1.39e-05	0.000401	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—CYP1A1—polycystic ovary syndrome	1.38e-05	0.000397	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	1.38e-05	0.000397	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	1.35e-05	0.00039	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	1.35e-05	0.00039	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—CYP1A1—polycystic ovary syndrome	1.34e-05	0.000385	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—CYP19A1—polycystic ovary syndrome	1.33e-05	0.000384	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—SRD5A1—polycystic ovary syndrome	1.32e-05	0.00038	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	1.3e-05	0.000375	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—MTHFR—polycystic ovary syndrome	1.29e-05	0.00037	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	1.28e-05	0.000369	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—STAR—polycystic ovary syndrome	1.26e-05	0.000363	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—MTHFR—polycystic ovary syndrome	1.25e-05	0.000359	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	1.25e-05	0.000359	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PNPLA2—polycystic ovary syndrome	1.24e-05	0.000358	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—TH—polycystic ovary syndrome	1.23e-05	0.000355	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—SLC2A4—polycystic ovary syndrome	1.2e-05	0.000346	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—GNAS—polycystic ovary syndrome	1.19e-05	0.000342	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—SRD5A1—polycystic ovary syndrome	1.18e-05	0.000339	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	1.13e-05	0.000326	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—NCOR1—polycystic ovary syndrome	1.13e-05	0.000326	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CYP19A1—polycystic ovary syndrome	1.13e-05	0.000325	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	1.12e-05	0.000324	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—HMMR—polycystic ovary syndrome	1.12e-05	0.000323	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	1.11e-05	0.00032	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	1.08e-05	0.000309	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—CYP1A1—polycystic ovary syndrome	1.07e-05	0.000309	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	1.07e-05	0.000308	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.06e-05	0.000305	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PPARG—polycystic ovary syndrome	1.04e-05	0.0003	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—POMC—polycystic ovary syndrome	1.03e-05	0.000296	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	1.03e-05	0.000295	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—INS—polycystic ovary syndrome	1.02e-05	0.000294	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	1.01e-05	0.000292	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PPARG—polycystic ovary syndrome	1.01e-05	0.000291	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—GNAS—polycystic ovary syndrome	1.01e-05	0.00029	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1e-05	0.000289	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	1e-05	0.000289	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—MTHFR—polycystic ovary syndrome	1e-05	0.000288	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—POMC—polycystic ovary syndrome	9.97e-06	0.000287	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—INS—polycystic ovary syndrome	9.91e-06	0.000285	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	9.77e-06	0.000281	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—NCOR1—polycystic ovary syndrome	9.6e-06	0.000276	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	9.56e-06	0.000275	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	9.55e-06	0.000275	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	9.45e-06	0.000272	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	9.25e-06	0.000266	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	9.14e-06	0.000263	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CYP1A1—polycystic ovary syndrome	9.1e-06	0.000262	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	8.96e-06	0.000258	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	8.72e-06	0.000251	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	8.72e-06	0.000251	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	8.62e-06	0.000248	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	8.52e-06	0.000245	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	8.51e-06	0.000245	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—MTHFR—polycystic ovary syndrome	8.48e-06	0.000244	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	8.26e-06	0.000238	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	8.24e-06	0.000237	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	8.17e-06	0.000235	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PPARG—polycystic ovary syndrome	8.12e-06	0.000234	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—POMC—polycystic ovary syndrome	8.01e-06	0.000231	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—INS—polycystic ovary syndrome	7.97e-06	0.000229	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	7.95e-06	0.000229	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	7.95e-06	0.000229	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	7.77e-06	0.000224	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	7.64e-06	0.00022	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	7.6e-06	0.000219	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	7.59e-06	0.000219	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	7.54e-06	0.000217	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	7.53e-06	0.000217	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	7.49e-06	0.000216	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	7.36e-06	0.000212	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	7.12e-06	0.000205	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	7.09e-06	0.000204	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	7.01e-06	0.000202	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	6.93e-06	0.000199	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PPARG—polycystic ovary syndrome	6.88e-06	0.000198	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	6.82e-06	0.000196	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—POMC—polycystic ovary syndrome	6.78e-06	0.000195	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.78e-06	0.000195	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—INS—polycystic ovary syndrome	6.75e-06	0.000194	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	6.73e-06	0.000194	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	6.71e-06	0.000193	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	6.68e-06	0.000192	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	6.47e-06	0.000186	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	6.36e-06	0.000183	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	6.26e-06	0.00018	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	6.21e-06	0.000179	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.18e-06	0.000178	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	6.14e-06	0.000177	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	6.09e-06	0.000175	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—TH—polycystic ovary syndrome	6.07e-06	0.000175	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	5.9e-06	0.00017	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	5.8e-06	0.000167	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	5.71e-06	0.000164	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	5.55e-06	0.00016	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—TH—polycystic ovary syndrome	5.41e-06	0.000156	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	5.27e-06	0.000152	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	4.95e-06	0.000143	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	4.95e-06	0.000143	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—TH—polycystic ovary syndrome	4.94e-06	0.000142	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	4.8e-06	0.000138	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	4.72e-06	0.000136	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	4.51e-06	0.00013	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	4.47e-06	0.000129	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	4.42e-06	0.000127	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	4.21e-06	0.000121	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	4.17e-06	0.00012	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	4.03e-06	0.000116	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	3.99e-06	0.000115	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	3.84e-06	0.000111	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	3.72e-06	0.000107	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	3.64e-06	0.000105	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	3.39e-06	9.77e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	3.38e-06	9.73e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	3.33e-06	9.6e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—INS—polycystic ovary syndrome	3.32e-06	9.54e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	3.02e-06	8.69e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	2.98e-06	8.57e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—INS—polycystic ovary syndrome	2.96e-06	8.52e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	2.75e-06	7.92e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	2.71e-06	7.81e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—INS—polycystic ovary syndrome	2.7e-06	7.77e-05	CbGpPWpGaD
